US pharmacy chain Rite Aid Corp. filed for bankruptcy in an effort to close unprofitable stores, address lawsuits over its role in the opioid pandemic and rework a debt load of roughly $4 billion.
After nearly two weeks watching his closest friends detail the collapse of his FTX crypto exchange, Sam Bankman-Fried is facing the toughest choice in his fraud trial so far: whether to defend himself on the witness stand.
Swedish retailer Hennes & Mauritz AB is planning a debut green bond sale, the latest effort by a fast fashion company to improve the sustainability of its business.
Wells Fargo & Co. is the first of the six biggest Wall Street banks to tap the US investment-grade market after reporting third-quarter earnings.
Neuberger Berman is submitting a shareholder proposal to Lions Gate Entertainment Corp., advocating for an end to the dual-class voting structure at the company ahead of a spinoff of its studio business.
Private equity firm Astira Capital Partners announced the final closing of its debut fund with $675 million of institutional capital commitments, exceeding its original target of $500 million.
Novo Nordisk A/S agreed to buy an experimental blood-pressure medicine from KBP Biosciences for as much as $1.3 billion, extending a string of recent deals to bolster its drug pipeline.
The tagline from Wall Street was that 2023 was the year of the bond. Instead, fund managers are coming to terms with one of the toughest years ever.
Donald Tusk is set to return as Poland’s prime minister, putting him in position to unlock billions in European Union funding and begin restoring independent institutions after eight years of nationalist rule.
It’s not just Poland’s nationalist leadership that’s been upset by a surprise election victory for the pro-European Union opposition.
